Sally Pipes: “CMS Officials Are Undermining Trump’s Push For Affordable Drugs”

Fierce competition for market share leads to massive discounting. In 2024 alone, biosimilars saved the U.S. healthcare system an estimated $20 million. Government price controls, however, impede market forces–and innovation.